Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Dec 2005 11:24 AM
RNS
Result of EGM
09 Dec 2005 11:43 AM
RNS
Holding(s) in Company
08 Dec 2005 03:31 PM
RNS
Holding(s) in Company
24 Nov 2005 11:37 AM
RNS
Holding(s) in Company
22 Nov 2005 04:12 PM
RNS
Blocklisting Interim Review
22 Nov 2005 12:17 PM
RNS
Holding(s) in Company
22 Nov 2005 07:00 AM
RNS
TroVax Notice of Allowance
17 Nov 2005 09:35 AM
RNS
Holding(s) in Company
16 Nov 2005 04:20 PM
RNS
Publication of Prospectus
16 Nov 2005 07:01 AM
RNS
Phase II trial with TroVax
16 Nov 2005 07:01 AM
RNS
Placing and Open Offer
15 Nov 2005 11:54 AM
RNS
Holding(s) in Company
02 Nov 2005 02:22 PM
RNS
Trovax & Proposed Fundraising
24 Oct 2005 01:49 PM
RNS
Trovax Clarification
24 Oct 2005 07:00 AM
RNS
Licence Agreement
20 Oct 2005 07:00 AM
RNS
Agreement with Sigma-Aldrich
19 Oct 2005 07:00 AM
RNS
Wyeth Preclinical Data
18 Oct 2005 11:30 AM
RNS
Additional Phase II Data
17 Oct 2005 07:00 AM
RNS
Final Phase II Results
06 Oct 2005 07:00 AM
RNS
Prelim Phase II Results
03 Oct 2005 01:54 PM
RNS
Change of Adviser
28 Sep 2005 05:55 PM
RNS
Holding(s) in Company
20 Sep 2005 07:00 AM
RNS
Interim Results
16 Sep 2005 06:22 PM
RNS
Holding(s) in Company
07 Sep 2005 07:01 AM
RNS
Appointment
05 Sep 2005 07:00 AM
RNS
Notice of Results
25 Aug 2005 02:11 PM
RNS
Holding(s) in Company
18 Aug 2005 10:06 AM
RNS
Holding(s) in Company
17 Aug 2005 01:56 PM
RNS
Holding(s) in Company
01 Aug 2005 07:00 AM
RNS
Completion of Clinical Trial
25 Jul 2005 07:00 AM
RNS
Awarded Research Grant
06 Jul 2005 04:09 PM
RNS
Holding(s) in Company
04 Jul 2005 07:00 AM
RNS
Two New Patents Granted
30 Jun 2005 04:00 PM
RNS
Holding(s) in Company
29 Jun 2005 04:00 PM
RNS
Holding(s) in Company
17 Jun 2005 03:21 PM
RNS
Holding(s) in Company
17 Jun 2005 11:12 AM
RNS
Chair Panel at BIO 2005
16 Jun 2005 04:47 PM
RNS
Holding(s) in Company
06 Jun 2005 03:00 PM
RNS
Director Shareholding
06 Jun 2005 07:00 AM
RNS
Licensing Agreement
03 Jun 2005 09:00 AM
RNS
Viragen Milestone
03 Jun 2005 07:00 AM
RNS
Innurex ASGT Data
19 May 2005 03:22 PM
RNS
Blocklisting Interim Review
16 May 2005 07:00 AM
RNS
Phase II trials of TroVax
12 May 2005 04:00 PM
RNS
Holding(s) in Company
12 May 2005 10:24 AM
RNS
2005 ASCO Annual Meeting
10 May 2005 12:05 PM
RNS
AGM Statement
09 May 2005 07:00 AM
RNS
European Patent Granted
05 May 2005 07:00 AM
RNS
Preclinical Effiancy Data
27 Apr 2005 04:00 PM
RNS
Holding(s) in Company

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings